دورية أكاديمية
The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients.
| العنوان: | The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients. |
|---|---|
| المؤلفون: | Fallah A; Department of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Sedighian H; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran., Behzadi E; Academy of Medical Sciences of the I.R. of Iran, Tehran, Iran., Havaei SA; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Kachuei R; Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran., Imani Fooladi AA; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: Imanifouladi.a@gmail.com. |
| المصدر: | Microbial pathogenesis [Microb Pathog] 2023 Jan; Vol. 174, pp. 105888. Date of Electronic Publication: 2022 Nov 17. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Academic Press Country of Publication: England NLM ID: 8606191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1208 (Electronic) Linking ISSN: 08824010 NLM ISO Abbreviation: Microb Pathog Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London ; Orlando : Academic Press, c1986- |
| مواضيع طبية MeSH: | COVID-19*, Humans ; SARS-CoV-2/metabolism ; Cytokines/metabolism ; Cytokine Release Syndrome ; Endotoxins |
| مستخلص: | The emergence of Coronavirus disease 2019 (Covid-19) is a global problem nowadays, causing health difficulty with increasing mortality rates, which doesn't have a verified treatment. SARS-CoV-2 infection has various pathological and epidemiological characteristics, one of them is increased amounts of cytokine production, which in order activate an abnormal unrestricted response called "cytokine storm". This event contributes to severe acute respiratory distress syndrome (ARDS), which results in respiratory failure and pneumonia and is the great cause of death associated with Covid-19. Endotoxemia and the release of bacterial lipopolysaccharides (endotoxins) from the lumen into the bloodstream enhance proinflammatory cytokines. SARS-CoV-2 can straightly interplay with endotoxins via its S protein, leading to the extremely elevating release of cytokines and consequently increase the harshness of Covid-19. In this review, we will discuss the possible role of viral-bacterial interaction that occurs through the transfer of bacterial products such as lipopolysaccharide (LPS) from the intestine into the bloodstream, exacerbating the severity of Covid-19 and cytokine storms. (Copyright © 2022 Elsevier Ltd. All rights reserved.) |
| References: | J Exp Med. 2004 Sep 20;200(6):749-59. (PMID: 15365096) Immunity. 2020 May 19;52(5):731-733. (PMID: 32325025) Eur J Immunol. 2017 May;47(5):765-779. (PMID: 28393361) Ann Clin Biochem. 2020 May;57(3):262-265. (PMID: 32266828) QJM. 2010 May;103(5):319-25. (PMID: 20219780) Nat Med. 2006 Dec;12(12):1365-71. (PMID: 17115046) Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73. (PMID: 9671771) Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507) J Cardiovasc Pharmacol. 2015 Dec;66(6):540-50. (PMID: 26322922) Shock. 2015 Apr;43(4):395-404. (PMID: 25768373) Lancet. 2002 Dec 7;360(9348):1831-7. (PMID: 12480361) Elife. 2020 Sep 15;9:. (PMID: 32930095) Mediators Inflamm. 2013;2013:495156. (PMID: 24385684) Diabetes. 2008 Jun;57(6):1470-81. (PMID: 18305141) Pathog Dis. 2013 Nov;69(2):87-100. (PMID: 23821437) J Med Virol. 2005 Feb;75(2):185-94. (PMID: 15602737) Int J Antimicrob Agents. 2020 May;55(5):105954. (PMID: 32234467) Biosci Rep. 2021 Feb 26;41(2):. (PMID: 33480978) FEBS Lett. 2002 Dec 4;532(1-2):107-10. (PMID: 12459472) Annu Rev Immunol. 2019 Apr 26;37:457-495. (PMID: 30676822) Biomed Res Int. 2018 May 9;2018:2819154. (PMID: 29854738) Clin Kidney J. 2021 Mar 16;14(6):1704-1707. (PMID: 34079619) Diabetes Care. 2014 Aug;37(8):2343-50. (PMID: 24824547) Front Microbiol. 2015 Jul 01;6:659. (PMID: 26191052) Infect Immun. 1981 Jun;32(3):1058-66. (PMID: 6166564) Laryngoscope. 2009 Jul;119(7):1406-11. (PMID: 19434681) Curr HIV/AIDS Rep. 2012 Mar;9(1):44-51. (PMID: 22193889) J Virol. 2004 Jun;78(11):5535-45. (PMID: 15140950) Front Immunol. 2021 Jan 25;11:607734. (PMID: 33569053) BMC Geriatr. 2021 Mar 17;21(1):186. (PMID: 33731018) Science. 2011 Oct 14;334(6053):245-9. (PMID: 21998394) Lancet Respir Med. 2016 Jan;4(1):59-72. (PMID: 26700442) Front Immunol. 2020 Jun 16;11:1446. (PMID: 32612617) PLoS One. 2011;6(10):e26050. (PMID: 22022504) Curr Opin Crit Care. 2016 Aug;22(4):347-53. (PMID: 27327243) Nature. 1987 Feb 5-11;325(6104):536-7. (PMID: 3543690) Trends Endocrinol Metab. 2020 Nov;31(11):835-847. (PMID: 33086076) Nat Metab. 2020 Mar;2(3):233-242. (PMID: 32694777) Science. 2011 Oct 14;334(6053):249-52. (PMID: 21998395) Intensive Care Med Exp. 2020 Dec 7;8(1):72. (PMID: 33284413) Respir Physiol Neurobiol. 2011 Jan 31;175(1):185-7. (PMID: 21075220) J Infect Dis. 2003 Oct 1;188(7):1032-9. (PMID: 14513424) Travel Med Infect Dis. 2020 Mar - Apr;34:101617. (PMID: 32165283) J Immunother Cancer. 2018 Jun 15;6(1):56. (PMID: 29907163) Am J Physiol Lung Cell Mol Physiol. 2016 Mar 1;310(5):L465-75. (PMID: 26589478) Science. 2020 May 1;368(6490):473-474. (PMID: 32303591) Curr Opin Microbiol. 2013 Apr;16(2):221-7. (PMID: 23597788) AIDS Res Hum Retroviruses. 2017 Sep;33(9):905-918. (PMID: 28398068) J Endocrinol Invest. 2023 Feb;46(2):235-259. (PMID: 36070177) Nat Commun. 2020 Nov 30;11(1):6122. (PMID: 33257679) PLoS Pathog. 2012 Feb;8(2):e1002464. (PMID: 22363214) Front Med (Lausanne). 2021 Aug 11;8:644751. (PMID: 34458281) J Immunol. 2013 Aug 1;191(3):1250-9. (PMID: 23804714) Virology. 2006 Jan 5;344(1):9-16. (PMID: 16364730) Thorax. 2008 Jun;63(6):519-25. (PMID: 18245149) J Med Microbiol. 2000 Jul;49(7):613-620. (PMID: 10882086) Diabetes Res Clin Pract. 2020 Nov;169:108467. (PMID: 32979419) Surgeon. 2012 Dec;10(6):350-6. (PMID: 22534256) J Clin Virol. 2012 Jan;53(1):38-42. (PMID: 22014848) J Mol Cell Biol. 2021 Mar 10;12(12):916-932. (PMID: 33295606) Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63. (PMID: 12829792) Annu Rev Med. 2011;62:361-80. (PMID: 21226616) Front Immunol. 2016 Aug 15;7:311. (PMID: 27574522) Science. 2014 Nov 7;346(6210):755-9. (PMID: 25378626) Chest. 2019 Oct;156(4):774-782. (PMID: 31265835) Am J Respir Crit Care Med. 1998 Aug;158(2):444-51. (PMID: 9700119) J Hepatobiliary Pancreat Surg. 2002;9(4):401-10. (PMID: 12483260) J Mol Endocrinol. 2013 Sep 11;51(2):R51-64. (PMID: 23943858) PLoS One. 2013 Dec 03;8(12):e81949. (PMID: 24312613) Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403. (PMID: 32334395) J Interferon Cytokine Res. 2015 Nov;35(11):875-87. (PMID: 26133750) PLoS Pathog. 2021 Feb 18;17(2):e1009306. (PMID: 33600486) J Periodontal Res. 2000 Feb;35(1):3-16. (PMID: 10791704) Infect Immun. 1996 Dec;64(12):4984-92. (PMID: 8945536) Eur J Clin Invest. 2000 Feb;30(2):167-79. (PMID: 10651843) Semin Immunopathol. 2017 Jul;39(5):529-539. (PMID: 28466096) J Immunol. 2014 Nov 15;193(10):5076-87. (PMID: 25311807) Klin Wochenschr. 1982 Jul 15;60(14):756-8. (PMID: 6181289) Semin Immunopathol. 2017 Jul;39(5):517-528. (PMID: 28555385) J Exp Med. 1996 Nov 1;184(5):1601-8. (PMID: 8920850) Cell Host Microbe. 2014 Jan 15;15(1):36-46. (PMID: 24439896) Aging (Albany NY). 2020 Apr 8;12(7):6049-6057. (PMID: 32267833) Front Pharmacol. 2020 Jul 29;11:1169. (PMID: 32848776) J Virol. 2003 Nov;77(21):11708-17. (PMID: 14557656) Diabetes. 2007 Jul;56(7):1761-72. (PMID: 17456850) Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32. (PMID: 22390970) Hong Kong Med J. 2005 Jun;11(3):189-99. (PMID: 15951584) Allergy. 2021 Feb;76(2):428-455. (PMID: 33185910) PLoS One. 2014 Jun 27;9(6):e101326. (PMID: 24971655) Hypertension. 2018 May;71(5):804-810. (PMID: 29581215) Clin J Am Soc Nephrol. 2008 Mar;3(2):431-6. (PMID: 18256376) PLoS One. 2011;6(12):e28378. (PMID: 22164280) Nat Rev Microbiol. 2016 Apr;14(4):197-204. (PMID: 26853118) Nat Med. 2006 Mar;12(3):289-95. (PMID: 16520776) BMC Infect Dis. 2021 Jan 19;21(1):84. (PMID: 33468070) Gastroenterology. 2020 Sep;159(3):944-955.e8. (PMID: 32442562) ACS Nano. 2020 May 26;14(5):5179-5182. (PMID: 32356654) J Biol Chem. 2008 Oct 17;283(42):28595-606. (PMID: 18678861) Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):745-755. (PMID: 33549450) J Infect Dis. 2003 Mar 15;187(6):1000-9. (PMID: 12660947) Cytokine Growth Factor Rev. 2020 Jun;53:25-32. (PMID: 32446778) Hepatology. 2006 Jul;44(1):126-39. (PMID: 16799989) Gut. 1999 Jul;45(1):70-6. (PMID: 10369707) Transplant Proc. 1993 Feb;25(1 Pt 2):1216-7. (PMID: 8442093) Cardiovasc Diabetol. 2009 Apr 15;8:20. (PMID: 19368716) Cytokine Growth Factor Rev. 2021 Apr;58:82-91. (PMID: 33573850) Virology. 1987 Apr;157(2):421-30. (PMID: 3029981) J Clin Invest. 1959 Jan;38(1 Part 2):213-65. (PMID: 13620784) Br Med J. 1919 Jan 4;1(3027):3-5. (PMID: 20769320) Clin Microbiol Rev. 2006 Jul;19(3):571-82. (PMID: 16847087) Cell Host Microbe. 2015 Oct 14;18(4):456-62. (PMID: 26468748) Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143) PLoS Pathog. 2013 Jan;9(1):e1003057. (PMID: 23326226) J Immunol. 2004 Jul 15;173(2):1336-43. (PMID: 15240728) Ir J Med Sci. 2022 Aug;191(4):1751-1758. (PMID: 34528185) J Clin Periodontol. 2001 Sep;28(9):879-85. (PMID: 11493359) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) J Biol Chem. 2005 Nov 4;280(44):36952-61. (PMID: 16120607) Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632) Int J Pept Res Ther. 2022;28(1):33. (PMID: 34931119) Thromb Res. 1995 Mar 1;77(5):441-52. (PMID: 7778059) J Infect Dis. 2010 Feb 1;201(3):346-53. (PMID: 20030555) Microbes Infect. 2006 May;8(6):1492-501. (PMID: 16697680) J Exp Med. 2004 Sep 20;200(6):761-70. (PMID: 15365095) Gastroenterology. 2020 May;158(6):1831-1833.e3. (PMID: 32142773) AIDS. 2005 Jan 28;19(2):107-17. (PMID: 15668535) PLoS Pathog. 2015 Feb 27;11(2):e1004626. (PMID: 25723501) |
| فهرسة مساهمة: | Keywords: Covid-19; Cytokine storm; Endotoxemia; Lipopolysaccharide |
| المشرفين على المادة: | 0 (Cytokines) 0 (Endotoxins) |
| تواريخ الأحداث: | Date Created: 20221119 Date Completed: 20230117 Latest Revision: 20230330 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC9671676 |
| DOI: | 10.1016/j.micpath.2022.105888 |
| PMID: | 36402345 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1096-1208 |
|---|---|
| DOI: | 10.1016/j.micpath.2022.105888 |